Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Three Benefits Of Centralizing Global Content For eCOA Migration
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
Aligning Wearable Data Collection Tith Visit Schedules Through EDC Integration
Learn how integrating with an EDC system can streamline monitoring and improve data quality in multi-period trials.
-
Drive Innovation In Clinical Trial Software: 3 Trends You Need To Watch
The clinical trial landscape is undergoing a transformative shift as technology increasingly shapes study design and execution. Explore three pivotal trends that are driving this evolution.
-
Benefits Of Delegating Your Oncology Trials Patient Screening Process
Explore the integration of Electronic Health Records (EHR) into oncology clinical trials, highlighting both challenges and potential advancements.
-
Transforming Field Rep Success
As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.
-
How SaaS Unlocks New Possibilities For Life Science Organizations
The rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
-
How eCOAs Can Benefit Clinical Trials
Learn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
Empowering Caregivers With ePRO Technology For Cancer Support
Explore the importance of involving caregivers in the care process and how electronic patient-reported outcomes technology can facilitate communication, tracking, and collaboration.
-
eCOA And Digital Platforms Reduce Diabetes Study Startup To 8 Weeks
See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.
FROM THE EDITOR
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders